Trials / Completed
CompletedNCT04439084
COVID-19 in Patients With Chronic Liver Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,025 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prospective Chart Review | Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease. |
Timeline
- Start date
- 2020-03-06
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
- First posted
- 2020-06-19
- Last updated
- 2021-08-09
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04439084. Inclusion in this directory is not an endorsement.